Abstract: The present disclosure provides human interleukin 4 receptor alpha antibody glucocorticoid receptor agonist conjugates and methods of using the conjugates for the treatment of inflammatory diseases, such as type 2 inflammatory diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202417104478-STATEMENT OF UNDERTAKING (FORM 3) [30-12-2024(online)].pdf | 2024-12-30 |
| 3 | 202417104478-Sequence Listing in PDF [30-12-2024(online)].pdf | 2024-12-30 |
| 4 | 202417104478-REQUEST FOR EXAMINATION (FORM-18) [30-12-2024(online)].pdf | 2024-12-30 |
| 5 | 202417104478-POWER OF AUTHORITY [30-12-2024(online)].pdf | 2024-12-30 |
| 6 | 202417104478-FORM 18 [30-12-2024(online)].pdf | 2024-12-30 |
| 7 | 202417104478-FORM 1 [30-12-2024(online)].pdf | 2024-12-30 |
| 8 | 202417104478-DRAWINGS [30-12-2024(online)].pdf | 2024-12-30 |
| 9 | 202417104478-DECLARATION OF INVENTORSHIP (FORM 5) [30-12-2024(online)].pdf | 2024-12-30 |
| 10 | 202417104478-COMPLETE SPECIFICATION [30-12-2024(online)].pdf | 2024-12-30 |
| 11 | 202417104478-FORM 3 [27-03-2025(online)].pdf | 2025-03-27 |
| 12 | 202417104478-Proof of Right [24-06-2025(online)].pdf | 2025-06-24 |